<?xml version="1.0" encoding="UTF-8"?>
<p>Most recommendations from dermatology societies [
 <xref ref-type="bibr" rid="CR19">19</xref>â€“
 <xref ref-type="bibr" rid="CR21">21</xref>], but also from other specialties that treat immune-mediated diseases (rheumatology [
 <xref ref-type="bibr" rid="CR22">22</xref>] and gastroenterology [
 <xref ref-type="bibr" rid="CR23">23</xref>]) recommend patients to discontinue or postpone immunosuppressive or biologic therapy in the event of COVID-19 diagnosis until the patient recovers from the infection. However, the decision to stop or withhold treatment is left to the joint consideration of the patient and physician, pondering the risk/benefit on a case-by-case basis depending on the risk of SARS-CoV-2 infection.
</p>
